ImmunoGen, Inc. – Consensus ‘buy’ rating and 5.0% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

ImmunoGen, Inc. which can be found using ticker (IMGN) now have 9 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between 22 and 8 calculating the average target price we see $14.96. Given that the stocks previous close was at $14.25 and the analysts are correct then there would likely be a percentage uptick in value of 5.0%. It’s also worth noting that there is a 50 day moving average of $6.76 while the 200 day moving average is $5.50. The total market capitalization for the company now stands at 3.28B. The current stock price for Coherent Corp. is currently 14.53 USD

The potential market cap would be $3,448,460,494 based on the market consensus.

USD

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of 0.47 and a -39.03% return on assets.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search